Announced Fri, 30 May · 18:27 IST

Financial Results for the Quarter and Year ended March 31, 2025.

Ebitda Margin ExpansionResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Kothari Fermentation & Biochem reported audited results for FY25 (year ended March 31, 2025) with revenue from operations of Rs. 11,423.10 lakhs, up about 4.9% from Rs. 10,888.09 lakhs in FY24. The company swung back to a net profit of Rs. 50.99 lakhs in FY25, compared to a net loss of Rs. 491.15 lakhs in FY24. Profit before tax for FY25 stood at Rs. 193.86 lakhs versus a loss of Rs. 392.53 lakhs a year earlier, while basic EPS improved to Rs. 0.54 from a negative Rs. 3.27. For Q4 FY25 (standalone), revenue was Rs. 3,217.87 lakhs and net profit was Rs. 105.13 lakhs, versus Rs. 3,198.54 lakhs and Rs. 86.96 lakhs in Q4 FY24. The auditor (Kothari Kuldeep & Co.) issued an unmodified opinion, and operating cash flow strengthened to Rs. 1,070.32 lakhs from Rs. 863.24 lakhs. The company also reduced both long-term and short-term borrowings during the year.

Likely market impact

A return to profitability, improved operating cash flow, and debt reduction are positive signs for shareholders. The clean audit opinion and modest revenue growth suggest a stabilizing business, though absolute profit levels remain thin relative to revenue.